Katherine K Tassiopoulos, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 64 | 2024 | 16764 | 2.170 |
Why?
|
Infectious Disease Transmission, Vertical | 13 | 2022 | 1331 | 0.910 |
Why?
|
Meconium | 4 | 2015 | 48 | 0.750 |
Why?
|
HIV Integrase Inhibitors | 4 | 2023 | 144 | 0.740 |
Why?
|
Condoms | 3 | 2021 | 321 | 0.690 |
Why?
|
Anti-HIV Agents | 15 | 2023 | 4320 | 0.670 |
Why?
|
Sexual Behavior | 6 | 2021 | 2040 | 0.600 |
Why?
|
Substance Abuse Detection | 4 | 2010 | 283 | 0.580 |
Why?
|
Antiretroviral Therapy, Highly Active | 4 | 2017 | 1896 | 0.560 |
Why?
|
Cocaine-Related Disorders | 4 | 2006 | 459 | 0.500 |
Why?
|
Pregnancy Complications, Infectious | 9 | 2022 | 2028 | 0.490 |
Why?
|
Viral Load | 9 | 2020 | 3299 | 0.480 |
Why?
|
Needle Sharing | 1 | 2013 | 24 | 0.480 |
Why?
|
Dangerous Behavior | 1 | 2012 | 66 | 0.440 |
Why?
|
Frail Elderly | 1 | 2017 | 690 | 0.410 |
Why?
|
Hair | 2 | 2006 | 479 | 0.400 |
Why?
|
Accidental Falls | 3 | 2022 | 1055 | 0.400 |
Why?
|
Data Collection | 1 | 2020 | 3341 | 0.390 |
Why?
|
Lymphocyte Subsets | 1 | 2012 | 315 | 0.380 |
Why?
|
Heroin Dependence | 3 | 2005 | 175 | 0.350 |
Why?
|
Anti-Retroviral Agents | 6 | 2019 | 1734 | 0.340 |
Why?
|
Substance Abuse, Intravenous | 1 | 2013 | 523 | 0.330 |
Why?
|
Self Disclosure | 3 | 2006 | 251 | 0.320 |
Why?
|
Medication Adherence | 5 | 2020 | 2047 | 0.310 |
Why?
|
Prenatal Exposure Delayed Effects | 5 | 2019 | 2393 | 0.290 |
Why?
|
Health Behavior | 2 | 2016 | 2624 | 0.270 |
Why?
|
Herpes Genitalis | 1 | 2007 | 141 | 0.270 |
Why?
|
HIV Protease Inhibitors | 1 | 2008 | 435 | 0.260 |
Why?
|
Herpesvirus 2, Human | 1 | 2007 | 185 | 0.260 |
Why?
|
Adolescent | 32 | 2023 | 85405 | 0.260 |
Why?
|
Hypercholesterolemia | 2 | 2011 | 1143 | 0.260 |
Why?
|
Substance-Related Disorders | 4 | 2021 | 4239 | 0.250 |
Why?
|
Longitudinal Studies | 10 | 2022 | 13880 | 0.250 |
Why?
|
Papillomavirus Vaccines | 2 | 2022 | 490 | 0.240 |
Why?
|
Occupations | 1 | 2006 | 517 | 0.240 |
Why?
|
Restaurants | 1 | 2006 | 236 | 0.230 |
Why?
|
Female | 62 | 2023 | 378853 | 0.220 |
Why?
|
Trichomonas Infections | 1 | 2022 | 43 | 0.220 |
Why?
|
Social Perception | 1 | 2006 | 424 | 0.210 |
Why?
|
Male | 53 | 2024 | 349022 | 0.210 |
Why?
|
Patient Acceptance of Health Care | 1 | 2016 | 3021 | 0.210 |
Why?
|
Trichomonas vaginalis | 1 | 2022 | 76 | 0.210 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2015 | 4424 | 0.210 |
Why?
|
Cocaine | 2 | 2006 | 1008 | 0.210 |
Why?
|
Self Report | 3 | 2016 | 3524 | 0.200 |
Why?
|
Adult | 33 | 2022 | 213394 | 0.200 |
Why?
|
Prevalence | 13 | 2022 | 15153 | 0.200 |
Why?
|
Cohort Studies | 18 | 2022 | 40389 | 0.200 |
Why?
|
Succinic Acid | 1 | 2021 | 82 | 0.190 |
Why?
|
Cholesterol | 2 | 2019 | 2900 | 0.190 |
Why?
|
Middle Aged | 30 | 2023 | 212863 | 0.190 |
Why?
|
Syphilis | 1 | 2022 | 225 | 0.180 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2014 | 4374 | 0.180 |
Why?
|
Humans | 70 | 2024 | 739398 | 0.180 |
Why?
|
Aging | 6 | 2022 | 8613 | 0.180 |
Why?
|
Cardiovascular Diseases | 6 | 2024 | 15070 | 0.180 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2022 | 2241 | 0.170 |
Why?
|
Diabetes Mellitus | 3 | 2024 | 5702 | 0.170 |
Why?
|
Drug Resistance, Viral | 2 | 2016 | 829 | 0.170 |
Why?
|
Chlamydia Infections | 1 | 2022 | 364 | 0.170 |
Why?
|
Young Adult | 14 | 2022 | 56255 | 0.170 |
Why?
|
Mental Disorders | 5 | 2019 | 6570 | 0.170 |
Why?
|
Tanzania | 3 | 2009 | 1303 | 0.170 |
Why?
|
Papillomavirus Infections | 2 | 2022 | 1585 | 0.160 |
Why?
|
Hepatitis C | 2 | 2023 | 1580 | 0.160 |
Why?
|
Gonorrhea | 1 | 2022 | 335 | 0.160 |
Why?
|
HIV | 5 | 2023 | 1607 | 0.160 |
Why?
|
DNA, Mitochondrial | 2 | 2021 | 804 | 0.160 |
Why?
|
United States | 17 | 2021 | 69573 | 0.160 |
Why?
|
Prospective Studies | 16 | 2023 | 53037 | 0.150 |
Why?
|
Risk Factors | 18 | 2024 | 71974 | 0.150 |
Why?
|
Hepatitis B | 1 | 2023 | 688 | 0.150 |
Why?
|
Child | 22 | 2022 | 77033 | 0.150 |
Why?
|
Sexually Transmitted Diseases | 1 | 2022 | 616 | 0.140 |
Why?
|
Metabolic Diseases | 1 | 2023 | 658 | 0.140 |
Why?
|
HIV-1 | 4 | 2021 | 6931 | 0.140 |
Why?
|
Metformin | 1 | 2023 | 827 | 0.140 |
Why?
|
Antibodies, Viral | 2 | 2019 | 3151 | 0.140 |
Why?
|
Bone Diseases | 1 | 2019 | 417 | 0.130 |
Why?
|
Logistic Models | 6 | 2020 | 13402 | 0.130 |
Why?
|
Puerto Rico | 1 | 2016 | 354 | 0.130 |
Why?
|
Age Factors | 8 | 2019 | 18349 | 0.130 |
Why?
|
CD4 Lymphocyte Count | 6 | 2020 | 2602 | 0.130 |
Why?
|
Safe Sex | 2 | 2021 | 140 | 0.130 |
Why?
|
Pregnancy | 14 | 2022 | 29002 | 0.120 |
Why?
|
Neurocutaneous Syndromes | 1 | 2015 | 45 | 0.120 |
Why?
|
Risk-Taking | 2 | 2011 | 986 | 0.120 |
Why?
|
Aged | 12 | 2023 | 162698 | 0.120 |
Why?
|
Odds Ratio | 7 | 2021 | 9846 | 0.120 |
Why?
|
Psychotropic Drugs | 1 | 2019 | 891 | 0.120 |
Why?
|
Treatment Failure | 1 | 2019 | 2614 | 0.110 |
Why?
|
Health Services | 1 | 2019 | 757 | 0.110 |
Why?
|
Haplotypes | 1 | 2020 | 2782 | 0.110 |
Why?
|
Papillomaviridae | 1 | 2019 | 1117 | 0.110 |
Why?
|
Aged, 80 and over | 6 | 2023 | 57650 | 0.110 |
Why?
|
Prenatal Injuries | 1 | 2012 | 13 | 0.110 |
Why?
|
Outpatient Clinics, Hospital | 2 | 2005 | 392 | 0.110 |
Why?
|
Caregivers | 4 | 2019 | 2067 | 0.100 |
Why?
|
Weight Gain | 4 | 2024 | 2278 | 0.100 |
Why?
|
Crime Victims | 1 | 2016 | 321 | 0.100 |
Why?
|
Fractures, Bone | 2 | 2015 | 1939 | 0.100 |
Why?
|
Socioeconomic Factors | 4 | 2015 | 7726 | 0.100 |
Why?
|
Cross-Sectional Studies | 10 | 2023 | 24714 | 0.100 |
Why?
|
Sex Offenses | 1 | 2016 | 347 | 0.100 |
Why?
|
HIV Seropositivity | 2 | 2019 | 966 | 0.100 |
Why?
|
Follow-Up Studies | 6 | 2020 | 38942 | 0.100 |
Why?
|
Bone Resorption | 1 | 2015 | 726 | 0.100 |
Why?
|
Bone Density | 2 | 2015 | 3471 | 0.100 |
Why?
|
Unsafe Sex | 1 | 2012 | 220 | 0.100 |
Why?
|
Infant, Newborn | 7 | 2022 | 25470 | 0.100 |
Why?
|
Premature Birth | 1 | 2022 | 1702 | 0.090 |
Why?
|
Marijuana Smoking | 1 | 2013 | 252 | 0.090 |
Why?
|
Tandem Mass Spectrometry | 2 | 2015 | 1156 | 0.090 |
Why?
|
Demography | 3 | 2019 | 1650 | 0.090 |
Why?
|
Integrases | 2 | 2023 | 532 | 0.090 |
Why?
|
Gestational Age | 2 | 2015 | 3486 | 0.090 |
Why?
|
Pregnancy Trimesters | 1 | 2010 | 192 | 0.090 |
Why?
|
Body Size | 1 | 2012 | 458 | 0.090 |
Why?
|
Antibodies, Bacterial | 1 | 2014 | 1465 | 0.080 |
Why?
|
Secondary Prevention | 1 | 2015 | 1516 | 0.080 |
Why?
|
Internet | 1 | 2020 | 3048 | 0.080 |
Why?
|
Counseling | 1 | 2016 | 1526 | 0.080 |
Why?
|
Alcohol Drinking | 2 | 2013 | 3945 | 0.080 |
Why?
|
Incidence | 6 | 2019 | 20913 | 0.080 |
Why?
|
Pilot Projects | 1 | 2020 | 8275 | 0.080 |
Why?
|
Population Surveillance | 2 | 2016 | 2629 | 0.070 |
Why?
|
Adenine | 1 | 2012 | 940 | 0.070 |
Why?
|
Hypolipidemic Agents | 1 | 2011 | 606 | 0.070 |
Why?
|
Proportional Hazards Models | 4 | 2021 | 12328 | 0.070 |
Why?
|
Executive Function | 1 | 2015 | 1356 | 0.070 |
Why?
|
Lactic Acid | 1 | 2011 | 1132 | 0.070 |
Why?
|
Adolescent Behavior | 2 | 2013 | 1146 | 0.070 |
Why?
|
Recurrence | 1 | 2017 | 8307 | 0.070 |
Why?
|
Weight Loss | 1 | 2017 | 2589 | 0.070 |
Why?
|
Motivation | 2 | 2006 | 1965 | 0.070 |
Why?
|
Cognition | 4 | 2023 | 6686 | 0.060 |
Why?
|
Quality of Life | 2 | 2023 | 12640 | 0.060 |
Why?
|
Psychology | 1 | 2006 | 351 | 0.060 |
Why?
|
Sexual Partners | 1 | 2009 | 727 | 0.060 |
Why?
|
Lymphocyte Activation | 1 | 2015 | 5522 | 0.060 |
Why?
|
Radioimmunoassay | 1 | 2004 | 918 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2019 | 4212 | 0.060 |
Why?
|
Mothers | 1 | 2014 | 2143 | 0.060 |
Why?
|
Cross-Over Studies | 1 | 2009 | 2030 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2012 | 2100 | 0.060 |
Why?
|
Point-of-Care Systems | 1 | 2011 | 1175 | 0.060 |
Why?
|
Risk Assessment | 3 | 2020 | 23294 | 0.050 |
Why?
|
Child, Preschool | 7 | 2016 | 40802 | 0.050 |
Why?
|
Exercise | 1 | 2019 | 5591 | 0.050 |
Why?
|
Benzoxazines | 1 | 2023 | 306 | 0.050 |
Why?
|
Inflammation | 3 | 2023 | 10534 | 0.050 |
Why?
|
Citric Acid | 1 | 2021 | 126 | 0.050 |
Why?
|
Cultural Diversity | 1 | 2005 | 357 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4663 | 0.050 |
Why?
|
Chlamydia trachomatis | 1 | 2022 | 246 | 0.050 |
Why?
|
Massachusetts | 1 | 2013 | 8669 | 0.050 |
Why?
|
Adenosine Monophosphate | 1 | 2022 | 277 | 0.050 |
Why?
|
Alanine Transaminase | 1 | 2023 | 591 | 0.050 |
Why?
|
Neisseria gonorrhoeae | 1 | 2022 | 238 | 0.050 |
Why?
|
Chromatography, Liquid | 2 | 2015 | 977 | 0.050 |
Why?
|
Infant | 7 | 2016 | 34923 | 0.040 |
Why?
|
HIV Seroprevalence | 1 | 2019 | 87 | 0.040 |
Why?
|
Hepatitis B virus | 1 | 2023 | 510 | 0.040 |
Why?
|
Condylomata Acuminata | 1 | 2019 | 82 | 0.040 |
Why?
|
Pharmacogenetics | 1 | 2023 | 679 | 0.040 |
Why?
|
Phenotype | 1 | 2017 | 16301 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 28901 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4454 | 0.040 |
Why?
|
RNA, Viral | 2 | 2019 | 2907 | 0.040 |
Why?
|
Maternal Exposure | 2 | 2015 | 952 | 0.040 |
Why?
|
Pregnancy Complications | 1 | 2010 | 2867 | 0.040 |
Why?
|
Developing Countries | 1 | 2009 | 2779 | 0.030 |
Why?
|
Cognition Disorders | 1 | 2010 | 4026 | 0.030 |
Why?
|
Smoking | 1 | 2012 | 8960 | 0.030 |
Why?
|
Immunity | 1 | 2022 | 1008 | 0.030 |
Why?
|
Attitude to Health | 1 | 2005 | 2047 | 0.030 |
Why?
|
Cervix Uteri | 1 | 2019 | 591 | 0.030 |
Why?
|
Sex Factors | 2 | 2019 | 10398 | 0.030 |
Why?
|
Hepatitis A Vaccines | 1 | 2014 | 29 | 0.030 |
Why?
|
Decision Making | 1 | 2009 | 3854 | 0.030 |
Why?
|
Domestic Violence | 1 | 2016 | 174 | 0.030 |
Why?
|
Publishing | 1 | 2022 | 828 | 0.030 |
Why?
|
Tetanus Toxoid | 1 | 2014 | 193 | 0.030 |
Why?
|
Child Behavior Disorders | 1 | 2019 | 805 | 0.030 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2019 | 616 | 0.030 |
Why?
|
Comorbidity | 2 | 2019 | 10362 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2723 | 0.030 |
Why?
|
Mental Health Services | 1 | 2005 | 1641 | 0.030 |
Why?
|
Postpartum Period | 1 | 2019 | 1070 | 0.030 |
Why?
|
Drug Utilization | 1 | 2019 | 1181 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2022 | 2049 | 0.030 |
Why?
|
Mexico | 1 | 2015 | 683 | 0.030 |
Why?
|
Boston | 1 | 2006 | 9314 | 0.030 |
Why?
|
Pregnancy Trimester, Third | 1 | 2015 | 568 | 0.030 |
Why?
|
Diabetes Complications | 1 | 2019 | 1356 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2014 | 791 | 0.030 |
Why?
|
Mood Disorders | 1 | 2019 | 1102 | 0.030 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2007 | 3908 | 0.030 |
Why?
|
Peru | 1 | 2015 | 879 | 0.030 |
Why?
|
Insurance Coverage | 1 | 2023 | 1891 | 0.020 |
Why?
|
HIV Seronegativity | 1 | 2011 | 209 | 0.020 |
Why?
|
Brazil | 1 | 2015 | 1264 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2011 | 441 | 0.020 |
Why?
|
Infant, Small for Gestational Age | 1 | 2012 | 438 | 0.020 |
Why?
|
Maternal-Fetal Exchange | 1 | 2011 | 454 | 0.020 |
Why?
|
Body Mass Index | 2 | 2019 | 12655 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2019 | 2583 | 0.020 |
Why?
|
Mortality | 1 | 2019 | 2851 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2021 | 6963 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2017 | 2410 | 0.020 |
Why?
|
Infant, Low Birth Weight | 1 | 2012 | 848 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2014 | 1348 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2019 | 2674 | 0.020 |
Why?
|
Intelligence | 1 | 2011 | 919 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2010 | 11699 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2019 | 62693 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12237 | 0.020 |
Why?
|
Mental Health | 1 | 2019 | 2946 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2014 | 21694 | 0.020 |
Why?
|
Chronic Disease | 1 | 2019 | 9133 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3863 | 0.010 |
Why?
|
Urban Health | 1 | 2005 | 547 | 0.010 |
Why?
|
Time Factors | 2 | 2015 | 40050 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6478 | 0.010 |
Why?
|
Child Development | 1 | 2012 | 2213 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2010 | 3194 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2010 | 4400 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10455 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2010 | 3752 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 29658 | 0.010 |
Why?
|
Research Design | 1 | 2012 | 5959 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2010 | 3401 | 0.010 |
Why?
|
Algorithms | 1 | 2012 | 13872 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14740 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2012 | 76631 | 0.000 |
Why?
|